The Cost-Effectiveness of Brentuximab Vedotin in Hodgkin Lymphoma in Sweden
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2303
https://www.valueinhealthjournal.com/article/S1098-3015(14)04233-8/fulltext
Title :
The Cost-Effectiveness of Brentuximab Vedotin in Hodgkin Lymphoma in Sweden
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04233-8&doi=10.1016/j.jval.2014.08.2303
First page :
A639
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1760